查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954677

全球数位PCR市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察以及未来预测（2026-2034）

Digital PCR Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

数位PCR市场成长驱动因素

由于对高精度分子诊断的需求不断成长、传染病和遗传疾病的蔓延以及技术的持续进步，全球数位PCR（dPCR）市场正经历快速成长。2025年市场规模为8.572亿美元，预计2026年将成长至10.432亿美元。到2034年，市场规模预计将达到57.7673亿美元，2026年至2034年的年复合成长率高达23.90%。

北美地区在2025年以43.70%的市场占有率引领全球市场，这得益于其对先进分子诊断技术的早期应用以及强大的生物製药研发基础设施。

市场概览

数位聚合酶炼式反应（dPCR）是传统PCR技术的升级版，能够对核酸（DNA/RNA）进行绝对定量。与即时PCR相比，dPCR具有更高的灵敏度、准确性和可重复性。主要优点包括高通量能力、更高的侦测精度、成本效益和更快的处理速度。

传染病、癌症和遗传疾病病例的不断增加是数位PCR市场的主要驱动力。收购增加、产品发布以及实验室应用范围的扩大进一步推动了行业成长。数位平台的技术进步也显着促进了市场扩张。

新冠疫情的影响

新冠疫情对数位PCR市场产生了正面影响。2020年，在全球对精准新冠病毒诊断需求激增的背景下，该市场实现了38.6%的显着成长，高于2019年的18.1%。

检测量的激增促使临床实验室和研究机构更多地采用数位PCR设备。儘管疫情后 COVID-19 病例减少导致检测量下降，但由于2021年常规诊断的恢復以及肿瘤学和基因检测应用领域的扩展，需求仍然强劲。用于生物製药应用的数位 PCR（dPCR）检测和设备的持续创新，进一步增强了市场在2025年至2034年预测期内的成长动力。

数位 PCR 市场趋势

从液滴式数位 PCR 过渡到晶片式数位 PCR 的

市场的一个显着趋势是从基于液滴的数位 PCR（ddPCR）逐步过渡到基于晶片的系统。虽然液滴系统目前仍占据主导地位，但基于晶片的技术可以降低交叉污染的风险并提高工作流程效率。基于晶片的检测具有处理速度更快、更便捷、更经济高效等优势。

不断上升的感染率和日益严重的癌症负担加速先进的基于晶片的数位 PCR 技术的应用。预计这一转变将在预测期内进一步推动数位PCR市场的成长。

市场成长驱动因素

技术进步

数位PCR系统（液滴、晶片、光束、晶体反应技术等）的持续创新显着提升了其性能和应用范围。市场参与者推出全自动整合系统，以支援检测和体外诊断应用。

公营机构不断增加的研发投入加速下一代dPCR平台的开发，并拓展其在肿瘤学、传染病检测和基因突变分析中的应用。

相对于即时PCR的优势

数位PCR可实现无需标准曲线的绝对定量，并提供更高的灵敏度和准确性。它在检测低病毒量和微小基因突变方面特别有效。这些优势使其极为适用于癌症突变检测和传染病诊断等应用。

人们越来越倾向于选择数位PCR而非传统即时PCR，预计这将进一步加速其在全球的普及应用。

限制因子

儘管成长前景广阔，但以下挑战可能会限制其扩张：

  • 数位PCR设备成本高
  • 需要熟练的专业人员
  • 与次世代定序（NGS）等替代技术的竞争
  • 低收入地区难以取得微流控耗材

这些因素可能会减缓发展中国家的采用速度。

市场区隔分析

依类型

市场依类型细分为以下几类：

  • 液滴式数位PCR
  • 晶片式数位PCR
  • 其他

到2026年，由于产品数量的增加，液滴式数位PCR细分市场将占据主导地位，市场占有率达到82.04%。传染病诊断领域已推出多种新型诊断方法并广泛应用。然而，由于晶片式系统在工作流程效率和污染控制方面具有优势，因此预计将保持稳定成长。

依产品类别

  • 设备
  • 试剂和耗材

预计到2026年，设备细分市场将占据 59.01%的市场占有率，这主要得益于产品发布量的增加和系统整合技术的进步。

预计试剂和耗材细分市场将以最高的年复合成长率成长，这主要得益于诊断试剂盒商业化的扩展和检测应用的增加。

依适应症类别

  • 传染病
  • 肿瘤
  • 遗传性疾病
  • 其他

预计遗传性疾病细分市场将推动市场成长，到2026年将占据 51.56%的市场占有率，这主要得益于其在检测基因突变方面的高灵敏度。

由于癌症发生率不断上升，肿瘤学领域预计将以显着的年复合成长率成长。由于数位 PCR 在病毒和细菌检测方面经临床验证的有效性，预计传染病领域将纪录最高的年复合成长率。

依最终使用者划分

  • 学术和研究机构
  • 临床实验室
  • 医院和诊所
  • 製药和生技公司

学术和研究机构细分市场在2026年将以 67.90%的市场占有率领先，反映出该技术在研究活动中的广泛应用。

随着传染病检测量的成长，临床实验室领域预计将以最高的年复合成长率扩张。

区域洞察

北美

北美地区在2025年创造 3.7468亿美元的收入，继续保持其在全球市场的主导地位。预计到2026年，美国市场规模将达到 4.2629亿美元。强劲的研发投入和高技术普及率推动该地区的成长。

欧洲

在研发投入增加和政府主导措施的支持下，预计欧洲市场将以适度的年复合成长率成长。预计到2026年，德国市场规模将达到 8,264万美元，英国市场规模将达到 3,309万美元。

亚太地区

预计亚太地区在预测期内将以最高的年复合成长率成长。

  • 预计到2026年，日本市场规模将达到 5,098万美元。
  • 预计到2026年，中国市场规模将达到 8,381万美元。
  • 预计到2026年，印度市场规模将达到 3,093万美元。

成长的驱动因素是医疗基础设施的改善和较高的疾病负担。

拉丁美洲、中东和非洲地区

由于医疗基础设施的发展和临床研究活动的增加，预计这些地区将经历显着成长。

该化合物预计2026年至2034年的年复合成长率（CAGR）为23.90%。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家和地区慢性病（癌症和传染病）盛行率（2025年）
  • 主要产业趋势：併购、业务合作等
  • 监理主要国家和地区概况
  • 数位PCR技术进展
  • 新冠疫情对市场的影响

第5章 全球数位PCR市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型
    • 液滴式数位PCR
    • 晶片式数位PCR
    • 其他
  • 市场分析、洞察与预测：依产品
    • 设备
    • 试剂和耗材
  • 市场分析、洞察与预测：依适应症
    • 传染病
    • 肿瘤
    • 遗传性疾病
    • 其他
  • 市场分析、洞察与预测：依最终用户
    • 医院和诊所
    • 製药和生物技术产业
    • 临床实验室
    • 学术和研究机构
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美数位PCR市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲数位PCR市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲地区

第8章 亚太数字PCR市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太国家/地区

第9章 拉丁美洲数位PCR市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家/地区国家/地区

第10章 中东与非洲数位 PCR 市场分析：洞察与预测（2021-2034）

  • 各国/地区概览
    • GCC
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • JN Medsys
    • Stilla
    • Sysmex Corporation
    • Standard BioTools Inc.
    • Precigenome LLC.
Product Code: FBI102014

Growth Factors of digital PCR Market

The global digital PCR market is experiencing rapid expansion due to rising demand for high-precision molecular diagnostics, increasing prevalence of infectious and genetic diseases, and continuous technological advancements. The market was valued at USD 857.2 million in 2025 and is projected to grow to USD 1,043.20 million in 2026. It is expected to reach USD 5,776.73 million by 2034, registering a strong CAGR of 23.90% during 2026-2034.

North America dominated the global market with a 43.70% market share in 2025, supported by early adoption of advanced molecular diagnostic technologies and strong biopharmaceutical research infrastructure.

Market Overview

Digital Polymerase Chain Reaction (dPCR) is an advanced form of conventional PCR technology that enables absolute quantification of nucleic acids (DNA/RNA). It offers enhanced sensitivity, precision, and reproducibility compared to real-time PCR. Key advantages include high throughput capability, improved detection accuracy, cost-effectiveness, and faster processing.

Rising cases of infectious diseases, cancer, and genetic disorders are major drivers of the digital PCR market. Increased acquisitions, product launches, and expansion of laboratory adoption further support industry growth. Technological advancements in digital platforms are also contributing significantly to market expansion.

COVID-19 Impact

The COVID-19 pandemic positively impacted the digital PCR market. In 2020, the market recorded a substantial growth rate of 38.6%, compared to 18.1% in 2019, driven by massive global demand for accurate COVID-19 diagnostics.

The surge in testing volumes led to increased adoption of digital PCR devices in clinical laboratories and research institutes. Although post-pandemic decline in COVID-19 cases reduced testing volumes, the resumption of routine diagnostics in 2021 and growing applications in oncology and genetic testing sustained strong demand. Continuous innovation in dPCR assays and equipment for biopharmaceutical applications further strengthened market momentum heading into the 2025-2034 forecast period.

Digital PCR Market Trends

Shift from Droplet to Chip-Based Digital PCR

A notable trend in the market is the gradual shift from droplet-based digital PCR (ddPCR) to chip-based systems. While droplet systems dominate currently, chip-based technologies reduce risks of cross-contamination and improve workflow efficiency. Chip-based tests offer advantages such as faster processing, simplicity, and cost-effectiveness.

Increasing incidence of infectious diseases and growing cancer burden are accelerating adoption of advanced chip-based digital PCR technologies. This shift is expected to further drive the digital PCR market growth during the forecast period.

Market Growth Drivers

Technological Advancements

Continuous innovation in digital PCR systems-including droplet, chip-based, beam, and crystal reaction techniques-has significantly enhanced performance and application scope. Market players are launching fully automated integrated systems to support both research and in vitro diagnostic applications.

Increased R&D investments by public and private organizations are accelerating development of next-generation dPCR platforms, expanding their use in oncology, infectious disease testing, and genetic mutation analysis.

Advantages Over Real-Time PCR

Digital PCR offers absolute quantification without reliance on standard curves, delivering higher sensitivity and precision. It is particularly effective in detecting low viral loads and minor genetic variations. These advantages make it highly suitable for applications such as cancer mutation detection and infectious disease diagnosis.

Growing preference for digital PCR over traditional real-time PCR is expected to drive strong adoption globally.

Restraining Factors

Despite strong growth prospects, certain challenges may limit expansion:

  • High cost of digital PCR instruments
  • Requirement for skilled professionals
  • Competition from alternative technologies such as Next-Generation Sequencing (NGS)
  • Limited availability of microfluidic consumables in low-income regions

These factors may slow adoption in developing economies.

Market Segmentation Analysis

By Type

The market is segmented into:

  • Droplet Digital PCR
  • Chip-Based Digital PCR
  • Others

The droplet dPCR segment dominated with a 82.04% market share in 2026, driven by increasing product launches and widespread use in infectious disease diagnostics. However, chip-based systems are projected to grow steadily due to workflow efficiency and contamination control advantages.

By Product

  • Instruments
  • Reagents & Consumables

The instruments segment accounted for 59.01% market share in 2026, supported by rising product launches and advanced system integration.

The reagents & consumables segment is expected to grow at the highest CAGR, fueled by increasing commercialization of diagnostic kits and expanding research applications.

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

The genetic disorders segment dominated with 51.56% share in 2026, driven by high sensitivity in detecting gene mutations.

The oncology segment is projected to grow at a substantial CAGR due to increasing cancer prevalence. The infectious diseases segment is expected to register the highest CAGR owing to the clinically proven effectiveness of digital PCR in viral and bacterial detection.

By End User

  • Academic & Research Organizations
  • Clinical Laboratories
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies

The academic & research organizations segment led the market with 67.90% share in 2026, reflecting extensive use in research studies.

The clinical laboratories segment is expected to expand at the highest CAGR due to growing infectious disease testing volumes.

Regional Insights

North America

North America generated USD 374.68 million in 2025, maintaining dominance in the global market. The U.S. market is projected to reach USD 426.29 million in 2026. Strong research funding and high technology adoption drive regional growth.

Europe

Europe is projected to grow at a moderate CAGR, supported by increasing R&D investments and government initiatives. Germany is expected to reach USD 82.64 million in 2026, while the UK is projected at USD 33.09 million in 2026.

Asia Pacific

Asia Pacific is expected to grow at the highest CAGR during the forecast period.

  • Japan market projected at USD 50.98 million in 2026
  • China market projected at USD 83.81 million in 2026
  • India market projected at USD 30.93 million in 2026

Growth is driven by improving healthcare infrastructure and high disease burden.

Latin America & Middle East & Africa

These regions are projected to witness significant growth due to improving healthcare infrastructure and increasing clinical research activities.

Competitive Landscape

The digital PCR market is consolidated, with leading players including:

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Stilla
  • Sysmex Corporation
  • Standard BioTools Inc.
  • JN Medsys

Bio-Rad Laboratories holds a dominant position due to its strong droplet digital PCR portfolio and strategic acquisitions. Partnerships, product launches, and geographic expansion strategies are strengthening the competitive landscape.

Conclusion

The global digital PCR market is poised for remarkable growth from USD 857.2 million in 2025 to USD 5,776.73 million by 2034, driven by rising infectious and genetic disease prevalence, technological advancements, and expanding research applications. With a projected CAGR of 23.90% from 2026-2034, the market is expected to witness substantial expansion, particularly across North America and Asia Pacific, positioning digital PCR as a critical technology in the future of molecular diagnostics.

Growth Rate CAGR of 23.90% from 2026-2034

Segmentation

By Type

  • Droplet Digital PCR
  • Chip-based Digital PCR
  • Others

By Product

  • Instruments
  • Reagents & Consumables

By Indication

  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Others

By End-user

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Industries
  • Clinical Laboratories
  • Academic & Research Organizations

By Geography

  • North America (By Type, Product, By Indication, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Product, By Indication, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Product, By Indication, End-user, and Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Chronic Diseases (Cancer and Infectious Disease), By Key Countries/Regions, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Regulatory Scenario, By Key Countries/Region
  • 4.4. Technological Advancements in Digital PCR
  • 4.5. Impact of Covid-19 on the Market

5. Global Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Droplet Digital PCR
    • 5.1.2. Chip-based Digital PCR
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Instruments
    • 5.2.2. Reagents & Consumables
  • 5.3. Market Analysis, Insights and Forecast - By Indication
    • 5.3.1. Infectious Diseases
    • 5.3.2. Oncology
    • 5.3.3. Genetic Disorders
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & Clinics
    • 5.4.2. Pharmaceutical & Biotechnology Industries
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Academic & Research Organisations
  • 5.5. Market Analysis, Insights and Forecast - By Geography
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Droplet Digital PCR
    • 6.1.2. Chip-based Digital PCR
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Instruments
    • 6.2.2. Reagents & Consumables
  • 6.3. Market Analysis, Insights and Forecast - By Indication
    • 6.3.1. Infectious Diseases
    • 6.3.2. Oncology
    • 6.3.3. Genetic Disorders
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Pharmaceutical & Biotechnology Industries
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Academic & Research Organisations
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Droplet Digital PCR
    • 7.1.2. Chip-based Digital PCR
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Instruments
    • 7.2.2. Reagents & Consumables
  • 7.3. Market Analysis, Insights and Forecast - By Indication
    • 7.3.1. Infectious Diseases
    • 7.3.2. Oncology
    • 7.3.3. Genetic Disorders
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Pharmaceutical & Biotechnology Industries
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Academic & Research Organisations
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Droplet Digital PCR
    • 8.1.2. Chip-based Digital PCR
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Instruments
    • 8.2.2. Reagents & Consumables
  • 8.3. Market Analysis, Insights and Forecast - By Indication
    • 8.3.1. Infectious Diseases
    • 8.3.2. Oncology
    • 8.3.3. Genetic Disorders
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Pharmaceutical & Biotechnology Industries
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Academic & Research Organisations
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of APAC

9. Latin America Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Droplet Digital PCR
    • 9.1.2. Chip-based Digital PCR
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Instruments
    • 9.2.2. Reagents & Consumables
  • 9.3. Market Analysis, Insights and Forecast - By Indication
    • 9.3.1. Infectious Diseases
    • 9.3.2. Oncology
    • 9.3.3. Genetic Disorders
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & Clinics
    • 9.4.2. Pharmaceutical & Biotechnology Industries
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Academic & Research Organisations
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Digital PCR Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Droplet Digital PCR
    • 10.1.2. Chip-based Digital PCR
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Product
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Consumables
  • 10.3. Market Analysis, Insights and Forecast - By Indication
    • 10.3.1. Infectious Diseases
    • 10.3.2. Oncology
    • 10.3.3. Genetic Disorders
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Pharmaceutical & Biotechnology Industries
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Academic & Research Organisations
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Bio-Rad Laboratories, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. JN Medsys
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. Stilla
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. Sysmex Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. Standard BioTools Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. Precigenome LLC.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (based on availability)

List of Tables

  • Table 1: Global Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 3: Global Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 4: Global Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 5: Global Digital PCR Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 7: North America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 8: North America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 9: North America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 10: North America Digital PCR Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: Europe Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 12: Europe Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 13: Europe Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 14: Europe Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 15: Europe Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 18: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 19: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 22: Latin America Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 23: Latin America Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 24: Latin America Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 28: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by Indication, 2021-2034
  • Table 29: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Digital PCR Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital PCR Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Digital PCR Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Digital PCR Market Value Share (%), by Product, 2025 & 2034
  • Figure 4: Global Digital PCR Market Value Share (%), by Indication, 2025 & 2034
  • Figure 5: Global Digital PCR Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: North America Digital PCR Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Figure 7: North America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 8: North America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 9: North America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 10: North America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 11: North America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 12: North America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 13: North America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: North America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 15: North America Digital PCR Market Value (USD million), By Country, 2025 & 2034
  • Figure 16: North America Digital PCR Market Value Share (%), By Country, 2025
  • Figure 17: Europe Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Europe Digital PCR Market Value Share (%), by Type, 2025
  • Figure 19: Europe Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 20: Europe Digital PCR Market Value Share (%), by Product, 2025
  • Figure 21: Europe Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 22: Europe Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 23: Europe Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 24: Europe Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Digital PCR Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 30: Asia Pacific Digital PCR Market Value Share (%), by Product, 2025
  • Figure 31: Asia Pacific Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 32: Asia Pacific Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 33: Asia Pacific Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 38: Latin America Digital PCR Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 40: Latin America Digital PCR Market Value Share (%), by Product, 2025
  • Figure 41: Latin America Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 42: Latin America Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 43: Latin America Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 44: Latin America Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Digital PCR Market Value (USD million), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Digital PCR Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Digital PCR Market Value (USD million), by Product, 2025 & 2034
  • Figure 50: Middle East & Africa Digital PCR Market Value Share (%), by Product, 2025
  • Figure 51: Middle East & Africa Digital PCR Market Value (USD million), by Indication, 2025 & 2034
  • Figure 52: Middle East & Africa Digital PCR Market Value Share (%), by Indication, 2025
  • Figure 53: Middle East & Africa Digital PCR Market Value (USD million), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Digital PCR Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Digital PCR Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Digital PCR Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Digital PCR Market Share (%), By Company, 2025